PlainPharmaWatch

CMS Open Payments · Program Year 2024

Immunocore Limited

Immunocore Limited reported $2,016,647.27 in payments to 1,028 physicians and teaching hospitals across 1,246 transactions.

See the rankings → How this is sourced
$2.0M
Total payments
1,246
Transactions
1,028
Recipients
+$319.1K
General Payments vs PY2023

Immunocore Limited reported $2,016,647.27 in payments to 1,028 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #445 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $2.0K per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Immunocore Limited pairs top-quartile payment volume with a moderately concentrated payment pattern.

#445
of 1,925 companies
0.0%
of all US industry payments
0.4%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Immunocore Limited's CMS-reported General Payments increased by $319.1K (+38.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: IMMUNOCORE LIMITEDPY2023: IMMUNOCORE LIMITEDPY2024: Immunocore Limited. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$821.3KPY2024$1.1M
PY2023
$821,347.14
PY2024
$1,140,462.83

How Immunocore Limited ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Immunocore Limited's total vs. every reporting company

CMS Open Payments, Program Year 2024

$2,016,647 Top 23% higher than 77% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Immunocore Limited

Immunocore Limited ranks #445 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $2,016,647.27 across 1,246 transactions to 1,028 physicians and teaching hospitals - $1.6K per transaction and $2.0K per recipient on average.

Of the 6 general-payment categories charted below, "Consulting Fee" is the largest at $552.2K across 37 transactions, 27.4% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 6 types of general payments, Immunocore Limited's largest category was "Consulting Fee" at $552.2K - 27.4% of the company's reported total.

How Immunocore Limited divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$552.2K2. Honoraria$498.1K3. Travel and Lodging$45.5K4. Food and Beverage$27.9K5. Space Rental or Facility …$16.8K6. Education$30.00
Payment Type Amount Transactions
Consulting Fee $552.2K 37
Honoraria $498.1K 69
Travel and Lodging $45.5K 86
Food and Beverage $27.9K 829
Space Rental or Facility Fees $16.8K 6
Education $30.00 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $993,605.69 (87.1%) of $1,140,462.83 in this company's General Payments records across 681 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Immunocore Limited

The five named recipients with the highest reported General Payments from this company

Roy Herbst$496.8KSushama Scalera$461.4KSajeve Thomas$13.0KYana Najjar$11.5KKatherine Wang$11.0K
  1. 1

    Roy Herbst

    $496,768.31 across 54 reported transactions

  2. 2

    Sushama Scalera

    $461,416.59 across 13 reported transactions

  3. 3

    Sajeve Thomas

    $12,971.72 across 19 reported transactions

  4. 4

    Yana Najjar

    $11,489.37 across 14 reported transactions

  5. 5

    Katherine Wang

    $10,959.70 across 19 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.6K. Average per recipient: $2.0K.

Total Amount

$2,016,647.27

Avg per Transaction

$1.6K

Avg per Recipient

$2.0K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Immunocore Limited Share

0.0%

#445 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Immunocore Limited

Omnia Medical, LLC

$2.0M 110 recipients

Roche Diagnostics Corporation

$2.0M 900 recipients

Shape Memory Medical Inc.

$2.0M 246 recipients

Calliditas Therapeutics US Inc.

$2.0M 12,051 recipients

Biohaven Pharmaceutical Holding Company Ltd.

$2.0M 0 recipients

Recor Medical Inc

$2.1M 2,012 recipients

Frequently Asked Questions

How much did Immunocore Limited pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $2,016,647.27 from Immunocore Limited to physicians and hospitals across 1,246 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Immunocore Limited? ▾
Averaging $2.0K per recipient, Immunocore Limited's 2024 payments reached 1,028 physicians and teaching hospitals.
What types of payments did Immunocore Limited make? ▾
6 categories of general payment make up Immunocore Limited's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $552.2K, representing 27.4% of the company's reported total.
How does Immunocore Limited rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Immunocore Limited ranks #445 by total payment amount.
What is the average payment size from Immunocore Limited? ▾
In 2024, Immunocore Limited averaged $1.6K per transaction across 1,246 transactions to 1,028 recipients.
Where does the payment data for Immunocore Limited come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Immunocore Limited's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.